BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31058283)

  • 21. Expression of prostate stem cell antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Barbisan F; Mazzucchelli R; Santinelli A; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
    Histopathology; 2010 Oct; 57(4):572-9. PubMed ID: 20955382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer.
    Nacerddine K; Beaudry JB; Ginjala V; Westerman B; Mattiroli F; Song JY; van der Poel H; Ponz OB; Pritchard C; Cornelissen-Steijger P; Zevenhoven J; Tanger E; Sixma TK; Ganesan S; van Lohuizen M
    J Clin Invest; 2012 May; 122(5):1920-32. PubMed ID: 22505453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Pan CX; Kinch MS; Kiener PA; Langermann S; Serrero G; Sun L; Corvera J; Sweeney CJ; Li L; Zhang S; Baldridge LA; Jones TD; Koch MO; Ulbright TM; Eble JN; Cheng L
    Clin Cancer Res; 2004 Feb; 10(4):1333-7. PubMed ID: 14977833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
    Marchal C; Redondo M; Padilla M; Caballero J; Rodrigo I; García J; Quian J; Boswick DG
    Histol Histopathol; 2004 Jul; 19(3):715-8. PubMed ID: 15168332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma.
    Tian L; Zhao L; Sze KM; Kam CS; Ming VS; Wang X; Zhang VX; Ho DW; Cheung TT; Chan LK; Ng IO
    Hepatology; 2022 Jul; 76(1):48-65. PubMed ID: 34767674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of ATF3 promotes hormone-induced prostate carcinogenesis and the emergence of CK5(+)CK8(+) epithelial cells.
    Wang Z; Kim J; Teng Y; Ding HF; Zhang J; Hai T; Cowell JK; Yan C
    Oncogene; 2016 Jul; 35(27):3555-64. PubMed ID: 26522727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated expression of angiogenin in prostate cancer and its precursors.
    Katona TM; Neubauer BL; Iversen PW; Zhang S; Baldridge LA; Cheng L
    Clin Cancer Res; 2005 Dec; 11(23):8358-63. PubMed ID: 16322296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis.
    Zhong C; Saribekyan G; Liao CP; Cohen MB; Roy-Burman P
    Cancer Res; 2006 Feb; 66(4):2188-94. PubMed ID: 16489020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study.
    Baspinar S; Bircan S; Orhan H; Kapucuoglu N; Bozkurt KK
    Pathol Res Pract; 2014 Jul; 210(7):412-8. PubMed ID: 24690321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
    Rehman I; Azzouzi AR; Cross SS; Deloulme JC; Catto JW; Wylde N; Larre S; Champigneuille J; Hamdy FC
    Hum Pathol; 2004 Nov; 35(11):1385-91. PubMed ID: 15668896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma.
    Altinok G; Powell IJ; Che M; Hormont K; Sarkar FH; Sakr WA; Grignon D; Liao DJ
    Prostate Cancer Prostatic Dis; 2006; 9(1):77-82. PubMed ID: 16331298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis.
    Lee SH; Luong R; Johnson DT; Cunha GR; Rivina L; Gonzalgo ML; Sun Z
    Oncogene; 2016 Feb; 35(6):702-14. PubMed ID: 25893287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
    Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
    J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conditional Deletion of Eaf1 Induces Murine Prostatic Intraepithelial Neoplasia in Mice.
    Pascal LE; Su F; Wang D; Ai J; Song Q; Wang Y; O'Malley KJ; Cross B; Rigatti LH; Green A; Dhir R; Wang Z
    Neoplasia; 2019 Aug; 21(8):752-764. PubMed ID: 31229879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.
    Geng C; Kaochar S; Li M; Rajapakshe K; Fiskus W; Dong J; Foley C; Dong B; Zhang L; Kwon OJ; Shah SS; Bolaki M; Xin L; Ittmann M; O'Malley BW; Coarfa C; Mitsiades N
    Oncogene; 2017 Aug; 36(33):4767-4777. PubMed ID: 28414305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression analysis of putative stem cell markers in human benign and malignant prostate.
    Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
    Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
    He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
    BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of erythropoietin receptor in human prostate carcinoma and high-grade prostatic intraepithelial neoplasia.
    Zhou T; Xu C; He M; Sun Y
    Prostate Cancer Prostatic Dis; 2008; 11(2):143-7. PubMed ID: 17637760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
    Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
    Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate.
    Bettendorf O; Schmidt H; Staebler A; Grobholz R; Heinecke A; Boecker W; Hertle L; Semjonow A
    Genes Chromosomes Cancer; 2008 Jul; 47(7):565-72. PubMed ID: 18383208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.